VS 8
VS 8 (Compound VS 8) is a potent, orally active VEGFR-2 inhibitor with significant anti-angiogenic effects. VS 8 induces cancer cell apoptosis and migration. VS 8 is active against CSCs (Cancer stem cells) [1].
Product Specifications
CAS Number
2471865-38-8
UNSPSC
12352005
Target
Apoptosis; Reactive Oxygen Species (ROS) ; VEGFR
Type
Reference compound
Related Pathways
Apoptosis; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/vs-8.html
Solubility
10 mM in DMSO
Smiles
CC(NC1=CC=C(OC2=C3C=CC=C(NC(NC4=CC=CC(C(F)(F)F)=C4)=O)C3=CC=C2)C=C1)=O
Molecular Formula
C26H20F3N3O3
Molecular Weight
479.45
References & Citations
[1]Siddharth J Modi, et al. Discovery of VEGFR-2 inhibitors exerting significant anticancer activity against CD44+ and CD133+ cancer stem cells (CSCs) : Reversal of TGF-β induced epithelial-mesenchymal transition (EMT) in hepatocellular carcinoma. Eur J Med Chem. 2020 Dec 1;207:112851.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
VEGFR2/KDR/Flk-1
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS720827-01 48 Well
Rabbit Microtubule-associated protein 2, MAP-2 ELISA Kit
Sign In for Pricing
View Details MBS720827-02 96 Well
Rabbit Microtubule-associated protein 2, MAP-2 ELISA Kit
Sign In for Pricing
View Details